Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1969 2
1970 2
1971 1
1972 1
1973 4
1974 3
1975 2
1976 2
1977 5
1978 6
1979 2
1980 5
1981 8
1982 3
1983 2
1984 7
1985 9
1986 11
1987 10
1988 8
1989 7
1990 15
1991 13
1992 14
1993 19
1994 20
1995 17
1996 21
1997 22
1998 30
1999 36
2000 33
2001 43
2002 48
2003 77
2004 98
2005 98
2006 125
2007 145
2008 140
2009 176
2010 229
2011 267
2012 307
2013 347
2014 338
2015 358
2016 369
2017 334
2018 405
2019 422
2020 493
2021 602
2022 554
2023 376
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

5,901 results

Results by year

Filters applied: . Clear all
Page 1
Mosunetuzumab: First Approval.
Kang C. Kang C. Drugs. 2022 Jul;82(11):1229-1234. doi: 10.1007/s40265-022-01749-5. Drugs. 2022. PMID: 35947358 Review.
Teclistamab: First Approval.
Kang C. Kang C. Drugs. 2022 Nov;82(16):1613-1619. doi: 10.1007/s40265-022-01793-1. Drugs. 2022. PMID: 36352205 Free PMC article. Review.
Opioid-induced fragile-like regulatory T cells contribute to withdrawal.
Zhu Y, Yan P, Wang R, Lai J, Tang H, Xiao X, Yu R, Bao X, Zhu F, Wang K, Lu Y, Dang J, Zhu C, Zhang R, Dang W, Zhang B, Fu Q, Zhang Q, Kang C, Chen Y, Chen X, Liang Q, Wang K. Zhu Y, et al. Among authors: kang c. Cell. 2023 Feb 2;186(3):591-606.e23. doi: 10.1016/j.cell.2022.12.030. Epub 2023 Jan 19. Cell. 2023. PMID: 36669483
The role of dendritic cells in allergic diseases.
Liu P, Kang C, Zhang J, Liu Y, Liu J, Hu T, Zeng X, Qiu S. Liu P, et al. Among authors: kang c. Int Immunopharmacol. 2022 Dec;113(Pt B):109449. doi: 10.1016/j.intimp.2022.109449. Epub 2022 Nov 17. Int Immunopharmacol. 2022. PMID: 36403519 Review.
Olutasidenib: First Approval.
Kang C. Kang C. Drugs. 2023 Mar;83(4):341-346. doi: 10.1007/s40265-023-01844-1. Drugs. 2023. PMID: 36848032 Review.
Retifanlimab: First Approval.
Kang C. Kang C. Drugs. 2023 Jun;83(8):731-737. doi: 10.1007/s40265-023-01884-7. Drugs. 2023. PMID: 37184754 Review.
Osteoarthritis and cardiovascular disease: A Mendelian randomization study.
Wang Z, Kang C, Xu P, Zhang S, Song JH, Wang D, Yuan S, Lee HJ, Zhang M, Wang Z, Sun H, Fan R. Wang Z, et al. Among authors: kang c. Front Cardiovasc Med. 2022 Nov 18;9:1025063. doi: 10.3389/fcvm.2022.1025063. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36465459 Free PMC article.
Research Advances in the Treatment of Allergic Rhinitis by Probiotics.
Liu P, Hu T, Kang C, Liu J, Zhang J, Ran H, Zeng X, Qiu S. Liu P, et al. Among authors: kang c. J Asthma Allergy. 2022 Oct 7;15:1413-1428. doi: 10.2147/JAA.S382978. eCollection 2022. J Asthma Allergy. 2022. PMID: 36238950 Free PMC article. Review.
5,901 results